We aimed to develop evidence-based multinational recommendations for the diagnosis and
management of gout. Using a formal voting process, a panel of 78 international …

Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) with anti-
inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial …

Objective. To examine the efficacy of chondroitin sulfate (CS) in the treatment of
osteoarthritis (OA) on the basis of a metaanalysis of controlled clinical trials. Methods. After …

Objective To develop evidence-based recommendations on how to investigate and follow-
up undifferentiated peripheral inflammatory arthritis (UPIA). Methods 697 rheumatologists …

Background This systematic meta-analysis on randomized controlled trials with diacerein
was performed to provide an evidence-based assessment of its symptomatic efficacy in the …

OBJECTIVE: To determine if the Disease Activity Index including a 28-joint count (DAS28) is
equally applicable for the total population with rheumatoid arthritis (RA). METHODS: Five …

Objective To evaluate the psychometric properties and validity of a modified version of the
Rheumatoid Arthritis Disease Activity Index (RADAI) without joint counts in order to facilitate …

Objective: To compare the performance of the several different diagnostic criteria sets
currently in use for polymyalgia rheumatica (PMR). Methods: 213 patients attending eight …

Background JAK-inhibitors (JAKi), recently approved in rheumatoid arthritis (RA), have
changed the landscape of treatment choices. We aimed to compare the effectiveness of four …

OBJECTIVE The aim of this study was to investigate the concentrations of T cell derived
cytokines in the synovial fluids (SFs) of patients with psoriatic arthritis (PsA) in comparison …